US Congress House Bill 1588 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 34-0)
Status: Introduced on April 16 2013 - 25% progression, died in committee
Action: 2013-06-03 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Medicare Drug Savings Act of 2013 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require drug manufacturers to pay the Secretary of Health and Human Services (HHS) drug rebates for rebate eligible (low-income) individuals. Excludes from Medicare coverage as a part D drug any drug or biological manufactured by a manufacturer that has not entered into and have in effect a rebate agreement with the Secretary. Requires a rebate agreement to require a drug or biological manufacturer to provide to the Secretary a rebate, determined according to a specified formula, for each rebate period ending after December 31, 2011, for any covered Medicare part D drug dispensed after that date to any rebate eligible individual for which payment was made by a prescription drug plan (PDP) sponsor or MedicareAdvantage (MA) organization for such period. Specifies a formula for determination of Medicaid rebate amounts for such drugs or biologicals. Amends SSA title XIX (Medicaid) to exclude any amounts paid under a rebate agreement from the determination of best price and average manufacturer price under the Medicaid program.

Medicare Drug Savings Act of 2013

Rep. Henry Waxman [D-CA]	Rep. Robert Andrews [D-NJ]	Rep. Madeleine Bordallo [D-GU]	Rep. Corrine Brown [D-FL]
Rep. Matthew Cartwright [D-PA]	Rep. Kathy Castor [D-FL]	Rep. Donna Christensen [D-VI]	Rep. David Cicilline [D-RI]
Rep. John Conyers [D-MI]	Rep. Diana DeGette [D-CO]	Rep. Donna Edwards [D-MD]	Rep. Raul Grijalva [D-AZ]
Rep. Jared Huffman [D-CA]	Rep. Ann Kuster [D-NH]	Rep. Barbara Lee [D-CA]	Rep. Sander Levin [D-MI]
Rep. Alan Lowenthal [D-CA]	Rep. Jim McDermott [D-WA]	Rep. Michael Michaud [D-ME]	Rep. George Miller [D-CA]
Rep. Gwen Moore [D-WI]	Rep. Jerrold Nadler [D-NY]	Rep. Gloria Negrete McLeod [D-CA]	Rep. Beto O'Rourke [D-TX]
Rep. Mark Pocan [D-WI]	Rep. Charles Rangel [D-NY]	Rep. Bobby Rush [D-IL]	Rep. John Sarbanes [D-MD]
Rep. Janice Schakowsky [D-IL]	Rep. Adam Schiff [D-CA]	Rep. Carol Shea-Porter [D-NH]	Rep. Jackie Speier [D-CA]
Rep. Mark Takano [D-CA]	Rep. Dina Titus [D-NV]

Date	Chamber	Action
2013-06-03	House	Referred to the Subcommittee on Health.
2013-04-19	House	Referred to the Subcommittee on Health.
2013-04-16	House	Referred to House Ways and Means
2013-04-16	House	Referred to House Energy and Commerce
2013-04-16	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

SB740 (Same As) 2013-04-16 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/113th-congress/house-bill/1588/all-info
Text	https://www.congress.gov/113/bills/hr1588/BILLS-113hr1588ih.pdf